Home Healthcare IT Appendicitis Market Size, Top Share, Demand, Forecast Analysis, 2031

Appendicitis Market

Appendicitis Market Size, Share & Trends Analysis Report By Type (Acute, Chronic), By Diagnosis and Treatment (Diagnosis, Treatment), By End-User (Hospitals and Clinics, Diagnostic Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI55601DR
Study Period 2019-2031 CAGR 4.9%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 7.8 Billion
Forecast Year 2031 Forecast Year Market Size USD 12.0 Billion
Largest Market North America Fastest Growing Market Europe
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global appendicitis market size was valued at USD 7.8 billion in 2022 and is projected to reach a value of USD 12.0 billion by 2031, registering a CAGR of 4.9% during the forecast period (2023-2031). Appendicitis instances and sickness awareness are increasing, the primary market drivers boosting Appendicitis market growth.

Appendicitis is a medical disorder that causes inflammation of the appendix, a tiny, finger-shaped pouch connected to the large intestine. The appendix is placed on the bottom right side of the abdomen. When the appendix is inflamed, it can cause a variety of symptoms and consequences. Appendicitis is a medical emergency that usually necessitates immediate surgical intervention.

The appendicitis market share is expected to expand throughout the projection period because of increased prevalence, awareness of the condition, and an aging population. Furthermore, rising healthcare expenditures and increased diagnostic procedure usage present opportunities for market expansion throughout the projection period.

Market Dynamics

Global Appendicitis Market Drivers

Growing Prevalence of Appendicitis

Appendicitis incidence and prevalence have a direct impact on the demand for medical treatments, such as appendectomy procedures and related healthcare resources. Appendicitis affects roughly 233 people per 100,000 in a given year, with a lifetime incidence risk ranging from 6.7 to 8.6%. Appendicitis is most common in those aged 11 to 20, then in people aged 21 to 30. The incidence of appendicitis is 11.5% in the 31-40 year age group and 3% in the 0-10 year age group.

Appendicitis is one of the most common surgical emergencies worldwide, according to World Journal of Surgery data, with an estimated lifetime risk of roughly 8.6%. Appendicitis occurs at different rates in different age groups and geographical areas. According to a study published in JAMA Surgery, males have a higher lifetime risk of appendicitis (9.4%) than girls (7.7%). The study also revealed age-related differences in appendicitis rates. There are regional differences in the prevalence of appendicitis. For example, populations with higher dietary fiber intake have a reduced incidence of appendicitis. This shows that lifestyle and nutritional factors may have a role in appendicitis prevalence. It is critical for healthcare planning to track trends in appendicitis incidence throughout time. Changes in lifestyle, food habits, or other factors may all impact the prevalence. As a result, the appendicitis market trend will improve.

Global Appendicitis Market Restraints:

Limited Access to Healthcare

Limited access to healthcare facilities, particularly in poor or rural locations, might cause delays in appendicitis diagnosis and surgical management. Rural or distant places may have fewer healthcare services, making timely medical care difficult. According to studies, people living in rural locations are more likely to face delays in receiving surgical procedures for illnesses such as appendicitis than those living in urban areas. Globally, 56% of the rural population lacks health coverage, compared to 22% in urban regions. According to the World Health Organization (WHO), up to 3.5 billion people worldwide lack access to essential health care.

Individuals may be hampered from getting immediate medical assistance due to financial restraints, a lack of health insurance, or other factors. According to a report from 2022, 112 million (44%) Americans cannot pay for healthcare. According to research, people with lower socioeconomic positions are more prone to put off getting medical attention for stomach pain that could be caused by appendicitis.

Global Appendicitis Market Opportunity:

Advancement in Minimally Invasive Techniques

Continued research and advancement in Appendectomy minimally invasive surgical procedures. Improving laparoscopic and robotic-assisted appendectomy methods can result in faster recovery, shorter hospital stays, and higher patient satisfaction. Compared to open surgery, laparoscopic Appendectomy is associated with reduced postoperative pain, a shorter hospital stay, and a faster return to normal activities. The use of robotic-assisted surgery for Appendectomy has risen in popularity. Every year, roughly 235 million major surgical procedures are performed worldwide, according to WHO (2021). Surgeons in North America choose minimally invasive surgical techniques because they attempt to cause the least damage to human tissues. Furthermore, introducing robotic technology into MI operations has improved outcomes and precise control of the process.

In addition, Olympus Corporation, in conjunction with Veran Medical Technologies Inc., debuted the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a range of five premium endoscopes for use in advanced diagnostic and therapeutic procedures, in April 2021. As a result, such actions are expected to generate market possibilities. Advances in minimally invasive appendectomy techniques are driven by a desire to improve patient outcomes, reduce complications, and optimize resource usage. Continuous research and technology advancements are refining these treatments and redefining the landscape of surgical interventions for appendicitis.

Regional Analysis

The global appendicitis market analysis is conducted in North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.

North America Dominates the Global Market

North America is the most significant global appendicitis market shareholder and is estimated to grow at a CAGR of 4.8% over the forecast period. North America will lead this market because there is a higher demand for good Treatment as appendicitis becomes more widespread, more people are aware of it, and it is more common. Appendicitis affects 1.1 individuals per 1,000 in the United States each year. Males have an 8.6% lifetime risk of appendicitis, while females have a 6.7% risk. Every year, around 250,000 appendectomies are performed in the United States. The United States is spending more on healthcare than in previous years, which could accelerate the growth of the medical device industry.

Additionally, in the United States, the lifetime risk of appendicitis is one in every fifteen. A perforated appendix is present in one-third of appendicitis cases. Healthcare spending in the United States has increased from prior years, which could lead to faster growth in the medical devices business, according to preliminary forecasts released in Health Affairs by CMS' Office of the Actuary. From 2019 to 2028, national healthcare spending in the United States is predicted to expand at a 5.4% annual pace, exceeding the GDP's average annual growth rate of 4.3%. According to the analysis, prices for medical goods and services will rise at an average annual rate of 2.4% from 2019 to 2028, accounting for 43% of overall predicted growth in personal healthcare spending.

Europe is anticipated to exhibit a CAGR of 5.2% over the forecast period. The appendicitis market in the region is expanding due to continuing research in molecular diagnostic technologies and the increased prevalence of infectious illnesses. In Europe, the incidence of acute appendicitis is believed to be 8%. In Northern Europe, the incidence rate is predicted to be one per 1,000 person-years. Furthermore, the German Appendicitis market had the highest market share, while the UK Appendicitis market was the fastest expanding in the European region.

The Asia-Pacific appendicitis market is predicted to develop at the quickest CAGR during the forecast period due to increased outpatient venues offering imaging services and their focus on forming partnerships to improve imaging services and patient care, according to Appendicitis Market insights. Furthermore, China's Appendicitis market had the greatest market share, while India's Appendicitis market was the fastest-growing in the Asia-Pacific region.

Report Scope

Report Metric Details
Segmentations
By Type
  1. Acute
  2. Chronic
By Diagnosis and Treatment
  1. Diagnosis
    1. Ultra Sound Imaging
    2. CT Scan
    3. Others
  2. Treatment
    1. Medication
    2. Surgery
    3. Others
By End-User
  1. Hospitals and Clinics
  2. Diagnostic Centers
Company Profiles Johnson and Johnson Services Inc (US) Pfizer Inc (US) Lupin (India) Siemens (Germany) Koninklijke Philips NV (Netherlands) Becton Dickinson and Company (US) Braun Melsungen AG (Germany) Cook (US) Medtronic (Ireland) Teva Pharmaceutical Industries Ltd (Israel).
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global appendicitis market is segmented based on type, diagnosis and Treatment, end-user, and region.

For better understanding, the type is further segmented into Acute and chronic.

Acute appendicitis holds the major market share. The most common type is acute appendicitis, which is defined by a rapid inflammation of the appendix caused by an obstruction of the appendix lumen. It is classified as a medical emergency. With 70% of market sales, the acute category dominated the market. Acute appendicitis is a common surgical emergency that is diagnosed by combining a clinical picture with a history, examination, and tests. Appendectomy has traditionally been used to treat acute appendicitis. For acute appendicitis, there are various described diagnostic scoring systems. Acute appendicitis is characterized by quick-onset stomach pain, nausea, vomiting, and fever. The pain usually begins near the umbilicus and spreads to the right lower quadrant. As a result, acute appendicitis accounts for the vast majority of appendectomy surgeries performed worldwide. The younger population is more likely to be affected, and immediate surgical intervention is critical to avoid problems. Acute appendicitis is the most common and well-defined kind, requiring immediate surgical surgery.

Chronic appendicitis is a less common and controversial form of appendicitis that is characterized by recurrent or chronic lower abdominal pain that is similar to acute appendicitis but with milder symptoms. Some doctors believe that chronic appendicitis involves a more progressive inflammatory process. Chronic appendicitis patients may have recurrent episodes of abdominal pain, but the symptoms are usually less severe than those of acute appendicitis. Diagnosis can be difficult because symptoms may be intermittent. The Treatment of chronic appendicitis remains debatable. Conservative therapies, such as antibiotics and lifestyle adjustments, are advocated by some practitioners, whereas Appendectomy may be recommended if symptoms continue. Chronic appendicitis is a less well-defined condition, with symptoms that may be recurring and milder. Diagnosis and therapeutic strategies for chronic appendicitis are still being debated in the medical community.

Diagnosis and Treatment segment is further bifurcated into diagnosis (ultrasound imaging, CT scan) and Treatment (Medication, surgery).

Treatment generates the most revenue. The treatment category controlled the market. Appendicitis treatment usually includes surgery to remove the inflamed appendix. An appendectomy is the surgical technique used to remove the appendix. It is the standard treatment for almost all appendicitis patients. In some circumstances, such as chronic appendicitis or when surgery is not immediately feasible, medication-based Treatment may be considered. Appendectomy, or surgical removal of the inflamed appendix, is the conventional and most common therapy for appendicitis. To operate, one of the following procedures, such as laparoscopic surgery or a laparotomy, is used. Laparoscopic surgery removes the appendix by a succession of microscopic incisions and specialized surgical instruments fed through the incisions. Laparoscopic surgery involves a shorter recovery period, resulting in fewer problems, such as hospital-acquired infections. Appendectomy is an effective and generally safe treatment for appendicitis. Compared to open surgery, studies have shown that laparoscopic Appendectomy reduces postoperative pain, hospital stay, and recovery time.

Ultrasound and CT-Scan are diagnostic sub-segments. Ultrasound imaging is a non-invasive diagnostic procedure that uses sound waves to create images of the abdominal area, including the appendix. CT scans provide detailed cross-sectional images of the abdomen using X-rays, offering a full view of the appendix and surrounding structures.

The market is sub-segmented into Hospitals and Clinics and Diagnostic Centers based on end-users.

Diagnostic Centers led the market growth. Diagnostic centers specialize in various medical imaging and diagnostic services, including ultrasound and CT scans for appendicitis diagnosis. Diagnosis centers are important in the first assessment of appendicitis using imaging examinations, adding to the diagnosis process before patients receive additional Treatment. The diagnostic centers made the greatest money. If the symptoms of appendicitis are not typical, tests are required to confirm the diagnosis and rule out other disorders. Appendicitis can now be diagnosed utilizing a range of diagnostic methods. An imaging test is the most accurate technique to tell if you have appendicitis or another sort of abdominal pain.

Hospitals and clinics are key healthcare centers where appendicitis patients seek medical attention, diagnosis, and Treatment. These facilities house medical specialists, surgical units, and diagnostic services required for complete appendicitis management. These are the key points of contact for appendicitis patients seeking medical attention. They offer services ranging from initial diagnosis to surgical intervention and postoperative care.

Market Size By Type

Market Size By Type
  • Acute
  • Chronic
  • Recent Developments

    Top Key Players

    Appendicitis Market Share of Key Players

    Appendicitis Market Share of Key Players
    Johnson and Johnson Services Inc (US) Pfizer Inc (US) Lupin (India) Siemens (Germany) Koninklijke Philips NV (Netherlands) Becton Dickinson and Company (US) Braun Melsungen AG (Germany) Cook (US) Medtronic (Ireland) Teva Pharmaceutical Industries Ltd (Israel). Others

    Frequently Asked Questions (FAQs)

    What is the market size of Appendicitis Market?
    The global Market of Appendicitis size was valued at USD 7.8 billion in 2022.
    The global Market of Appendicitis growing at a CAGR of 4.9% from (2023–2031).
    The Diagnostic Centers sector is expected to dominate over the forecast period.
    Johnson and Johnson Services Inc (US), Pfizer Inc (US), Lupin (India), Siemens (Germany), Koninklijke Philips NV (Netherlands), Becton, Dickinson and Company (US), Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Teva Pharmaceutical Industries Ltd (Israel)., are the prominent players in the Appendicitis Market.
    Growing Prevalence of Appendicitis are some key drivers supporting the growth of the Appendicitis Market.


    We are featured on :